Keywords: Mitsubishi Tanabe, Bipha, Nipro, Joint venture dissolved, Blood products

Mitsubishi Tanabe to take full control of Bipha JV

Article | 03 September 2012

Japanese drug major Mitsubishi Tanabe Pharma (TYO: 4508) has agreed to acquire the 49% holding (20,580 shares) held by fellow Japan based Nipro ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in